Myriad Genetics, Inc. revenue breakdown overview

Myriad Genetics, Inc. revenue for the last year amounted to 837.60 M USD, the most of which — 364.50 M USD — came from its highest performing source at the moment, Hereditary Cancer, the year earlier bringing 327.80 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Myriad Genetics, Inc. 769.50 M USD, and the year before that — 671.70 M USD.